Zobrazeno 1 - 10
of 87
pro vyhledávání: '"M Schwanstecher"'
Autor:
C. Schwanstecher, Oliver Thews, S. Comagic, C-Y. Shiue, Markus Piel, Peter J. Feilen, B Wängler, M. Schwanstecher, Stephan Schneider, Frank Rösch, A. Alavi, Ralf Schirrmacher, Esther Schirrmacher, S. Höhnemann
Publikováno v:
Nuclear Medicine and Biology. 31:639-647
18F-labeled non-sulfonylurea hypoglycemic agent (S)-2-(2-[(18)F]fluoroethoxy)-4-((3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl)-methyl)-benzoic acid ([(18)F]repaglinide), a derivative of the sulfonylurea-receptor (SUR) ligand repaglinide, was
Publikováno v:
Cell Calcium. 33:175-184
Ca(2+)/calmodulin-dependent protein kinase II is a member of a broad family of ubiquitously expressed Ca(2+) sensing serine/threonine-kinases. Ca(2+)/calmodulin-dependent protein kinase II is highly expressed in insulin secreting cells and is associa
Autor:
Esther Schirrmacher, H. H. Klein, M. Schwanstecher, Stephan Schneider, W. Schechinger, C. Schwanstecher, S. Überberg
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 115
Autor:
M. Schwanstecher, C. Schwanstecher, A. Korobeynikov, E. Schirrmacher, H. H. Klein, Sandra Ueberberg, Stephan Schneider, W. Schechinger
Publikováno v:
Regulatory peptides. 139(1-3)
The search for novel SUR1-ligands originates from the idea to influence the in vivo behaviour by adding new structural moieties to the glibenclamide structure while preserving its binding affinity. Important application of novel conjugates might be t
Publikováno v:
Diabetologie und Stoffwechsel. 1
Autor:
S. Comagic, Mathias Schreckenberger, Frank Rösch, Esther Schirrmacher, K. Oberholzer, Oliver Thews, M. Schwanstecher, Andreas Bauman, Peter Bartenstein, Harald Klein, Markus Piel, C. Schwanstecher, A. Korobeynikov, P. J. Feilen, Abass Alavi, Stephan Schneider, Ralf Schirrmacher, Hans-Georg Buchholz, C. Y. Shiue, Matthias M. Weber
Publikováno v:
Experimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 113(7)
Pancreatic islet cell mass (PICM) is a major determinant of the insulin secretory capacity in humans. Currently, the only method for accurate assessment of the PICM is an autopsy study. Thus, development of a technique allowing the non-invasive quant
Autor:
C. Y. Shiue, M. Schwanstecher, Frank Rösch, H. G. Bucholz, K. Oberholzer, Oliver Thews, Stephan Schneider, Abass Alavi, Ralf Schirrmacher, P. J. Feilen, Matthias M. Weber, Esther Schirrmacher, Mathias Schreckenberger
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 112
In diabetic patients the pancreatic islet cell mass (PICM) is a major determinant of the quantity of insulin that can be secreted. In type 1 diabetic patients the PICM is markedly reduced due to autoimmune destruction of the insulin producing pancrea
Autor:
C. Schwanstecher, Oliver Thews, P. J. Feilen, Markus Piel, E. Schirrmacher, Ralf Schirrmacher, Stephan Schneider, Matthias M. Weber, B Wängler, Frank Rösch, S. Comagic, M. Schwanstecher
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 112
Publikováno v:
Diabetes. 49(9)
In pancreatic beta-cells, cytosolic [ATP(4-)] critically controls insulin secretion via inhibition of ATP-sensitive potassium (KATP) channels. These channels are heteromultimers composed with a 4:4 stoichiometry of an inwardly rectifying K+ channel s
Autor:
M, Schwanstecher, C, Schwanstecher, F, Chudziak, U, Panten, J P, Clement, G, Gonzalez, L, Aguilar-Bryan, J, Bryan
Publikováno v:
Methods in enzymology. 294